Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KAMN
1851
DELISTED
Kaman Corp
KAMN
| $2.87M | ﹤0.01% |
128,522
+91,922
| +251% | +$2.23M |
|
1852
Opko Health
OPK
$978M
| $2.86M | ﹤0.01% |
2,286,543
-549,800
| -19% | -$866K |
|
1853
iShares MSCI Indonesia ETF
EIDO
$494M
| $2.85M | ﹤0.01% |
127,400
+90,900
| +249% | +$2.1M |
|
|
LBC
1854
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.85M | ﹤0.01% |
256,668
-2,582
| -1% | -$30.3K |
|
1855
Coeur Mining
CDE
$17.9B
| $2.85M | ﹤0.01% |
+846,695
| New | +$3.01M |
|
1856
4D Molecular Therapeutics
FDMT
$543M
| $2.85M | ﹤0.01% |
128,100
+59,000
| +85% | +$911K |
|
|
MORF
1857
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.84M | ﹤0.01% |
106,100
-33,900
| -24% | -$926K |
|
1858
US Physical Therapy
USPH
$1.16B
| $2.83M | ﹤0.01% |
34,923
-14,400
| -29% | -$1.21M |
|
1859
Federated Hermes
FHI
$4.8B
| $2.83M | ﹤0.01% |
+77,800
| New | +$2.73M |
|
1860
Protagonist Therapeutics
PTGX
$8.78B
| $2.82M | ﹤0.01% |
258,867
-140,900
| -35% | -$1.19M |
|
1861
StoneX
SNEX
$9.2B
| $2.82M | ﹤0.01% |
149,835
-94,977
| -39% | -$1.76M |
|
1862
Graham Corp
GHM
$1.24B
| $2.82M | ﹤0.01% |
292,868
-22,900
| -7% | -$212K |
|
1863
Equity Bancshares
EQBK
$1.06B
| $2.81M | ﹤0.01% |
86,100
-4,700
| -5% | -$162K |
|
|
EXK
1864
Endeavour Silver
EXK
$2.63B
| $2.81M | ﹤0.01% |
868,100
+239,500
| +38% | +$806K |
|
1865
Claros Mortgage Trust
CMTG
$237M
| $2.81M | ﹤0.01% |
191,100
+6,200
| +3% | +$97.4K |
|
1866
Paysign
PAYS
$509M
| $2.81M | ﹤0.01% |
1,088,154
-56,679
| -5% | -$142K |
|
1867
iHeartMedia
IHRT
$573M
| $2.8M | ﹤0.01% |
456,427
+231,900
| +103% | +$1.79M |
|
1868
Repay Holdings
RPAY
$332M
| $2.8M | ﹤0.01% |
347,300
+100,100
| +40% | +$720K |
|
1869
The Bancorp
TBBK
$2.99B
| $2.79M | ﹤0.01% |
98,400
+5,400
| +6% | +$149K |
|
1870
SiTime
SITM
$16.6B
| $2.78M | ﹤0.01% |
27,400
-228,200
| -89% | -$21.6M |
|
1871
Silvercrest Asset Management
SAMG
$78.7M
| $2.78M | ﹤0.01% |
148,287
-10,200
| -6% | -$184K |
|
1872
Tanger
SKT
$4.67B
| $2.78M | ﹤0.01% |
154,821
+3,106
| +2% | +$55.8K |
|
|
RUTH
1873
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $2.78M | ﹤0.01% |
179,300
-152,700
| -46% | -$2.68M |
|
1874
Atlantic Union Bankshares
AUB
$6.12B
| $2.77M | ﹤0.01% |
78,981
-98,300
| -55% | -$3.36M |
|
1875
Trinity Industries
TRN
$2.57B
| $2.77M | ﹤0.01% |
93,800
-27,500
| -23% | -$766K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.